Correlation of PET/CT Findings and Histopathology after Neoadjuvant Therapy in Non-Small Cell Lung Cancer
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Objectives: Prediction of histopathological response with PET/CT scans after neoadjuvant chemoradiotherapy is limited by confounding factors which have been evaluated in this analysis. Methods:18 F-2-fluoro-2-deoxy-D-glucose (FDG)-PET/CT findings [standard uptake value (SUV), residual tumor volume] were correlated with histopathological parameters of the resection specimens (tumor cell density, necrosis, scar, macrophage infiltration) in patients with locally advanced non-small cell lung cancer (stage IIIA/IIIB) after neoadjuvant induction chemotherapy (platinum-based doublet) and concurrent chemoradiotherapy (cisplatin/vinorelbine/45 Gy). Results: Sixty patients [40 male/20 female, median age 56 years (34–78)] completed induction therapy, 46 patients (stage IIIA/IIIB: 16/30; squamous cell carcinoma 41%, adenocarcinoma 48%, large cell carcinoma 11%) were resected. Pathologic complete response of the primary tumor was observed in 19 patients (41%) with a broad range of SUV mean (0.4–9.8, mean 3.0) after neoadjuvant therapy. A high rate of histopathological complete remissions (44%) was observed in tumors with a postinduction SUV >2.5 and volumes larger than the median (7.9 cm 3) before resection. SUV mean was positively correlated with the macrophage score (r = 0.39, p = 0.007) and tumor cell density (r = 0.32, p = 0.03). Conclusions: These observations suggest that postinduction FDG uptake should be interpreted with caution in larger residual tumor volumes, since high SUV levels may be due to macrophage infiltration and not viable tumor tissue.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Classification and Grading of Gastritis: The Updated Sydney System
Dixon, M. F., Genta, R. M., Yardley, J. H., & Correa, P. (1996) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199610000-00001 · Cited by 5,185
(1992) · PubMed Central · doi:10.2967/jnumed.120.251744a · Cited by 1,172
Cited by
Travis, W. D., Dacic, S., Wistuba, I., Sholl, L., Adusumilli, P., Bubendorf, L., Bunn, P., Cascone, T., Chaft, J., Chen, G., et al. (2020) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2020.01.005 · Cited by 465
Pataer, A., Kalhor, N., Correa, A. M., Raso, M. G., Erasmus, J. J., Kim, E. S., Behrens, C., Lee, J. J., Roth, J. A., Stewart, D. J., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318247504a · Cited by 374
“prediction of chemotherapy response with positron emission tomography/computed tomography findings have also been confounded by false-positive F-fluorodeoxyglucose avidity due to macrophage infiltration.(11) Several small studies have suggested that the degree of tumor regression after neoadjuvant therapy as determine…”
BackgroundRadiomic phenotype features predict pathological response in non-small cell lung cancer
Coroller, T. P., Agrawal, V., Narayan, V., Hou, Y., Grossmann, P., Lee, S. W., Mak, R. H., & Aerts, H. J. W. L. (2016) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2016.04.004 · Cited by 327
William, W. N., Pataer, A., Kalhor, N., Correa, A. M., Rice, D. C., Wistuba, I. I., Heymach, J., Lee, J. J., Kim, E. S., Munden, R., et al. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182774108 · Cited by 138
“It has recently been reported that the prediction of histopathologic response in patients with locally advanced NSCLC who received neoadjuvant chemotherapy followed by curative surgery is more accurate when defined by a combined radiologic-metabolic response using CT and FDG-PET compared to radiologic and metabolic re…”
Bahce, I., Vos, C. G., Dickhoff, C., Hartemink, K. J., Dahele, M., Smit, E. F., Boellaard, R., Hoekstra, O. S., & Thunnissen, E. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.04.010 · Cited by 25
Metadata
- Authors
- Poettgen, C., Theegarten, D., Eberhardt, W., Levegruen, S., Gauler, T., Krbek, T., Stamatis, G., Teschler, H., Kuehl, H., Bockisch, A., & Stuschke, M.
- Venue
- Oncology
- Publisher
- S. Karger AG
- Published
- 2007
- Volume
- 73
- Issue
- 5-6
- Pages
- 316-323
- ISSN
- 0030-2414 (ISSN-L)
- 1423-0232
- OpenAlex
- W1974408915
- Cited by
- 51
- References
- 2
- FWCI
- 3.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Correlation of PET/CT Findings and Histopathology after Neoadjuvant Therapy in Non-Small Cell Lung Cancer. https://app.cochat.ai/papers/10.1159/000134474
- The paper
- Poettgen, C., Theegarten, D., Eberhardt, W., Levegruen, S., Gauler, T., Krbek, T., Stamatis, G., Teschler, H., Kuehl, H., Bockisch, A., & Stuschke, M. (2007). Correlation of PET/CT Findings and Histopathology after Neoadjuvant Therapy in Non-Small Cell Lung Cancer. Oncology. https://doi.org/10.1159/000134474
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.